Phathom Pharmaceuticals (PHAT) announced the appointment of Ted Schroeder to its Board of Directors.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHAT:
- Phathom Pharmaceuticals Announces Leadership Transition in 2025
- Phathom Pharmaceuticals appoints Basta as President, CEO
- Phathom Pharmaceuticals partners with Kenan Thompson for GERD awareness
- Biotech Alert: Searches spiking for these stocks today
- Phathom Pharmaceuticals: Favorable Risk/Reward Profile Amid Challenges and Growth Opportunities